Results for:(84 found)
Dec 16, 2013 3:01PM on Top StocksBy MSN Money Partner

Companies are having a tough time convincing doctors, patients and insurers to give new treatments a try.

Nov 13, 2013 11:56AM on Top StocksBy InvestorPlace

It's a fool's game to hold these. Get out while you can.

Tags: BMYFBX
Nov 8, 2013 10:34AM on Top StocksBy TheStreet.com Staff

With close to $20 billion in cash on the balance sheet, Merck is one key acquisition away from turning its fortunes around.

Nov 1, 2013 9:18AM on Top StocksBy TheStreet.com Staff

JNJ's strong dividend yield of 2.9 percent and its attractive balance means investors won't die in waiting room.

Sep 19, 2013 10:59AM on Top StocksBy TheStreet Staff

Iclusig is not any more toxic than its competing leukemia drugs and its sales potential remains strong.

Sep 16, 2013 11:57AM on Top StocksBy MSN Money Partner

Under Armour is downgraded to 'neutral,' and Bristol-Myers is upgraded to 'overweight.'

Aug 27, 2013 9:13AM on Top StocksBy Jim Cramer

Sorry to be so prosaic about this, but as long oil's not shooting through the roof, investors need to take very little action.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

TOP STOCKS

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More